PharmaCielo (TSE:PCLO) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
PharmaCielo, a leading cultivator and producer of cannabis extracts, has announced an anticipated reinstatement for trading on the TSX Venture Exchange following a successful resolution of previous regulatory issues. The company has also been progressing with its efficiency program, reducing its monthly cash burn rate, and is finalizing a private placement to boost its finances. Additionally, PharmaCielo is extending its international footprint with an impending acquisition of Siam Ventures Corporation in Thailand.
For further insights into TSE:PCLO stock, check out TipRanks’ Stock Analysis page.